Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15737612rdf:typepubmed:Citationlld:pubmed
pubmed-article:15737612lifeskim:mentionsumls-concept:C0019704lld:lifeskim
pubmed-article:15737612lifeskim:mentionsumls-concept:C0025245lld:lifeskim
pubmed-article:15737612lifeskim:mentionsumls-concept:C1550548lld:lifeskim
pubmed-article:15737612lifeskim:mentionsumls-concept:C1555714lld:lifeskim
pubmed-article:15737612lifeskim:mentionsumls-concept:C1705654lld:lifeskim
pubmed-article:15737612pubmed:issue2lld:pubmed
pubmed-article:15737612pubmed:dateCreated2005-3-1lld:pubmed
pubmed-article:15737612pubmed:abstractTextFor penetration of human immunodeficiency virus type 1 (HIV-1), formation of fusion-pores might be required for accumulating critical numbers of fusion-activated gp41, followed by multiple-site binding of gp120 with receptors, with the help of fluidization of the plasma membrane and viral envelope. Correlation between HIV-1 infectivity and fluidity was observed by treatment of fluidity-modulators, indicating that infectivity was dependent on fluidity. A 5% decrease in fluidity suppressed the HIV-1 infectivity by 56%. Contrarily, a 5% increase in fluidity augmented the infectivity by 2.4-fold. An increased temperature of 40 degrees C or treatment of 0.2% xylocaine after viral adsorption at room temperature enhanced the infectivity by 2.6- and 1.5-fold, respectively. These were inhibited by anti-CXCR4 peptide, implying that multiple-site binding was accelerated at 40 degrees C or by xylocaine. Thus, fluidity of both the plasma membrane and viral envelope was required to form the fusion-pore and to complete the entry of HIV-1.lld:pubmed
pubmed-article:15737612pubmed:languageenglld:pubmed
pubmed-article:15737612pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15737612pubmed:citationSubsetIMlld:pubmed
pubmed-article:15737612pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15737612pubmed:statusMEDLINElld:pubmed
pubmed-article:15737612pubmed:monthAprlld:pubmed
pubmed-article:15737612pubmed:issn0006-291Xlld:pubmed
pubmed-article:15737612pubmed:authorpubmed-author:MaedaYosukeYlld:pubmed
pubmed-article:15737612pubmed:authorpubmed-author:AkaikeTakaaki...lld:pubmed
pubmed-article:15737612pubmed:authorpubmed-author:YusaKeisukeKlld:pubmed
pubmed-article:15737612pubmed:authorpubmed-author:HaradaShinjiSlld:pubmed
pubmed-article:15737612pubmed:authorpubmed-author:MondeKazuakiKlld:pubmed
pubmed-article:15737612pubmed:issnTypePrintlld:pubmed
pubmed-article:15737612pubmed:day8lld:pubmed
pubmed-article:15737612pubmed:volume329lld:pubmed
pubmed-article:15737612pubmed:ownerNLMlld:pubmed
pubmed-article:15737612pubmed:authorsCompleteYlld:pubmed
pubmed-article:15737612pubmed:pagination480-6lld:pubmed
pubmed-article:15737612pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15737612pubmed:meshHeadingpubmed-meshheading:15737612...lld:pubmed
pubmed-article:15737612pubmed:meshHeadingpubmed-meshheading:15737612...lld:pubmed
pubmed-article:15737612pubmed:meshHeadingpubmed-meshheading:15737612...lld:pubmed
pubmed-article:15737612pubmed:meshHeadingpubmed-meshheading:15737612...lld:pubmed
pubmed-article:15737612pubmed:meshHeadingpubmed-meshheading:15737612...lld:pubmed
pubmed-article:15737612pubmed:meshHeadingpubmed-meshheading:15737612...lld:pubmed
pubmed-article:15737612pubmed:meshHeadingpubmed-meshheading:15737612...lld:pubmed
pubmed-article:15737612pubmed:meshHeadingpubmed-meshheading:15737612...lld:pubmed
pubmed-article:15737612pubmed:meshHeadingpubmed-meshheading:15737612...lld:pubmed
pubmed-article:15737612pubmed:year2005lld:pubmed
pubmed-article:15737612pubmed:articleTitleInfluence of membrane fluidity on human immunodeficiency virus type 1 entry.lld:pubmed
pubmed-article:15737612pubmed:affiliationDepartment of Medical Virology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan. biodef@gpo.kumamoto-u.ac.jplld:pubmed
pubmed-article:15737612pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15737612pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:920entrezgene:pubmedpubmed-article:15737612lld:entrezgene
entrez-gene:155971entrezgene:pubmedpubmed-article:15737612lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15737612lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15737612lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15737612lld:pubmed